1. Home
  2. INTZ vs AIDX Comparison

INTZ vs AIDX Comparison

Compare INTZ & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intrusion Inc.

INTZ

Intrusion Inc.

HOLD

Current Price

$0.91

Market Cap

16.9M

ML Signal

HOLD

AIDX

20/20 Biolabs Inc. Common Stock

N/A

Current Price

$1.78

Market Cap

19.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
INTZ
AIDX
Founded
1983
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Communications Equipment
Precision Instruments
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.9M
19.5M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
INTZ
AIDX
Price
$0.91
$1.78
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$5.75
N/A
AVG Volume (30 Days)
146.1K
100.4K
Earning Date
05-12-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
71.78
N/A
EPS
N/A
N/A
Revenue
$7,015,000.00
N/A
Revenue This Year
$36.12
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
21.56
N/A
52 Week Low
$0.75
$1.51
52 Week High
$2.64
$14.09

Technical Indicators

Market Signals
Indicator
INTZ
AIDX
Relative Strength Index (RSI) 48.43 18.42
Support Level $0.86 $1.51
Resistance Level $1.20 $2.08
Average True Range (ATR) 0.07 0.18
MACD 0.01 0.20
Stochastic Oscillator 62.70 26.19

Price Performance

Historical Comparison
INTZ
AIDX

About INTZ Intrusion Inc.

Intrusion Inc is a cybersecurity company based in Plano, Texas. The company offers its customers access to its exclusive threat intelligence database containing the historical data, known associations, and reputational behavior of Internet Protocol addresses. Its platform combines threat intelligence, malicious traffic identification, and automated threat response, and is designed to help organizations proactively identify and stop malicious activity in their networks. Its solutions include INTRUSION Shield, INTRUSION TraceCop, and INTRUSION Savant. The company operates in single segment.

About AIDX 20/20 Biolabs Inc. Common Stock

20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.

Share on Social Networks: